Urofollitropin Terminated Phase 2 Trials for Ovulation induction therapy Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00553514AS900672-Enriched in Ovulation Induction